77 results
424B3
PRTG
Portage Biotech Inc
28 Feb 24
Prospectus supplement
5:19pm
for Good Reason (as defined in the CEO Services Agreement). PDS may terminate the CEO’s employment immediately upon his death, upon a period … of disability or without Just Cause (as defined in the CEO Services Agreement). In the event that the CEO’s employment is terminated due to his death
6-K
EX-99.1
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
death, upon a period of disability or without Just Cause (as defined in the CEO Services Agreement). In the event that the CEO’s employment is terminated … due to his death or Disability (as defined in the CEO Services Agreement), for Good Reason or without Just Cause, he will be entitled to accrued
S-8
EX-4.2
PRTG
Portage Biotech Inc
1 Dec 23
Registration of securities for employees
4:05pm
termination for Cause or the Participant’s death or Disability, the Participant may exercise his or her Option within ninety (90) days of termination … will terminate, and the Shares covered by such Option will revert to the Plan.
(v) Death of Participant. If a Participant dies while a Service
424B3
PRTG
Portage Biotech Inc
28 Nov 23
Prospectus supplement
4:03pm
and Restated 2021 Equity Incentive Plan), (3) the participant’s death, or (4) the participant’s Disability (as defined in the Amended and Restated 2021 … in the CEO Services Agreement). PDS may terminate the CEO’s employment immediately upon his death, upon a period of disability or without Just Cause
6-K
EX-99.1
PRTG
Portage Biotech Inc
28 Nov 23
Current report (foreign)
4:01pm
)), (2) the participant’s Separation from Service (as defined in the Amended and Restated 2021 Equity Incentive Plan), (3) the participant’s death, or (4 … upon his death, upon a period of disability or without Just Cause (as defined in the CEO Services Agreement). In the event that the CEO’s employment
6-K
EX-99.1
jgbfu5c5ifbc1h
29 Aug 23
Current report (foreign)
4:01pm
6-K
EX-99.1
bs6gaz5
29 Nov 22
Current report (foreign)
4:58pm
6-K
EX-99.1
mpk6zy ovsgkips
9 Nov 22
Portage Biotech Announces Clinical Trial Collaboration Agreement with Merck
4:01pm
6-K
EX-99.1
yydk7ypfkldfzbs
7 Oct 22
Notice of Annual General Meeting
3:06pm
6-K
EX-4.1
h2wwfh
22 Sep 22
Current report (foreign)
4:07pm
6-K
EX-99.1
8oq6ruvr4wo8 z690ko4
29 Aug 22
Current report (foreign)
4:00pm